MitoSciences Overview

  • Founded
  • 2004
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 11
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

MitoSciences General Information

Description

Developer of monoclonal antibodies and immunoassay for mitochondrial enzymes. The company's marketed portfolio comprises over 200 products in the areas of metabolism and apoptosis, including antibody cocktails, cell fractionation kits, sandwich ELISA kits, in-cell ELISA, flow cytometry antibodies, and enzyme activity assays.

Contact Information

Website
www.mitosciences.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Discovery Tools (Healthcare)
Acquirer
Abcam
Primary Office
  • 1850 Millrace Drive
  • Eugene, OR 97403
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MitoSciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MitoSciences‘s full profile, request access.

Request a free trial

MitoSciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial